is bpc 157 banned by wada Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing WADA's 2022 Prohibited List now

medial and lateral compartments with or without patella resurfacing (total knee arthroplasty)), 27130 (Arthroplasty, acetabular and proximal femoral prosthetic replacement (total hip arthroplasty), with or without autograft or allograft), 23472 (Arthroplasty, glenohumeral joint

its driven by hormones

Form Sterile Solution Supplied in a sealed 10ml vial for safe handling, easy measurement, and precise control in laboratory settings

The FDAs Stance and Why It Misses the Mark In 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance , meaning it raises significant safety concerns. The agency specifically cited risks of immunogenicity , peptide-related impurities , and lack of sufficient safety data for human use